Skip to main content
Guru Sonpavde, MD, Oncology, Boston, MA, Brigham and Women's Hospital

GuruPSonpavdeMD

Oncology Boston, MA

Genitourinary Oncology

Director, Bladder Cancer, Dana Farber Cancer Institute Associate Professor of Medicine Harvard Medical School Boston, MA, USA

Dr. Sonpavde is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sonpavde's full profile

Already have an account?

  • Office

    Dana Farber Cancer Institute
    450 Brookline Ave, D924
    Boston, MA 02215
    Phone(617) 632-2429
    Fax(617) 632-2165
  • Is this information wrong?

Summary

  • Current and Emerging Agents to Treat Advanced Bladder Cancer

    Current and Emerging Agents to Treat Advanced Bladder Cancer

    A New Prognostic Model for Post-Platinum PD-L1 Inhibitors Treatment of Urothelia

    A New Prognostic Model for Post-Platinum PD-L1 Inhibitors Treatment of Urothelial Carcinoma

    Immunotherapy Outcomes in Pure vs Mixed Urothelial Carcinoma Histology

    Immunotherapy Outcomes in Pure vs Mixed Urothelial Carcinoma Histology

Education & Training

  • Indiana University School of Medicine
    Indiana University School of MedicineFellowship, Hematology/Oncology, 1995 - 1998
  • Nassau University Medical Center
    Nassau University Medical CenterResidency, Internal Medicine, 1992 - 1995
  • Christian Medical College Vellore
    Christian Medical College VelloreClass of 1990

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2017 - 2022
  • AL State Medical License
    AL State Medical License 2012 - 2017
  • TX State Medical License
    TX State Medical License 2003 - 2013
  • AZ State Medical License
    AZ State Medical License 2001 - 2003
  • TN State Medical License
    TN State Medical License 1999 - 2002
  • IN State Medical License
    IN State Medical License 1995 - 1999
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Development and Validation of a Prognostic Model for Overall Survival in Chemotherapy-Naïve Men with Metastatic Castration-Resistant Prostate Cancer  
    G Sonpavde, C S Higano, T M Beer, Annals of Oncology
  • Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International Collaboration  
    Richard S Foster, Lawrence H Einhorn, Christopher J Sweeney, Guru Sonpavde, Costantine Albany, Chandra K Flack, The Journal of Urology
  • Nomogram to predict the benefit from salvage systemic therapy for advanced urothelial carcinoma.  
    Sonpavde G, Pond GR, Fougeray R, Bellmunt J., BJU Int, 2014

Lectures

  • 5-factor prognostic model for survival of patients with metastatic urothelial carcinoma receiving three different post-platinum PD-L1 inhibitors. 
    2019 ASCO Annual Meeting - 6/1/2019
  • A phase 3 randomized study of neoadjuvant chemotherapy (NAC) alone or in combination with nivolumab (NIVO) ± BMS-986205 in cisplatin-eligible muscle invasive bladder ... 
    2019 ASCO Annual Meeting - 6/1/2019

Authored Content

  • GU Updates Abound at ASCO 2021June 2021
  • Cancer treatment: is a clinical trial right for youMarch 2019
  • Immunotherapy for cancer therapy: What you need to knowJanuary 2019

Press Mentions

  • GU Updates Abound at ASCO 2021
    GU Updates Abound at ASCO 2021June 15th, 2021

Professional Memberships

Hospital Affiliations